脓毒性休克.pptxVIP

SEPTIC SHOCK;;;;Clinical case;variable;;Definition;;Diagnose;;; Validation;Evolution;Evolution; .; .; .;Rivers, E., et al.,. New England Journal of Medicine, 2001. 345(19): p. 1368-1377.;EGDT;EGDT;Surviving sepsis campaign(SSC);;;Epidemiology ;Park, D.W., et al. Journal of Korean medical science, 2012. 27(11): p. 1308-1314.;Epidemiology;Epidemiology;;;SURVIVING SEPSIS CAMPAIGN BUNDLES;;Resuscitation ;Resuscitation;vasopressors;Resuscitation;Corticosteroids;;;Diagnose pathogen;;Combination therapy;;;Management in ICU;Management in ICU;;;;Things To Think About;Recent development;Things To Think About;;Doubt about CVP;Things To Think About;Things To Think About;Reference;13. Angus, D.C., et al., Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Critical care medicine, 2001. 29(7): p. 1303-1310.14. Martin, G.S., et al., The epidemiology of sepsis in the United States from 1979 through 2000. New England Journal of Medicine, 2003. 348(16): p. 1546-1554.15. Rangel-Frausto, M.S., et al., The natural history of the systemic inflammatory response syndrome (SIRS). JAMA: the journal of the American Medical Association, 1995. 273(2): p. 117-123.16. Brun-Buisson, C., et al., Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. JAMA: the journal of the American Medical Association, 1995. 274(12): p. 968-974.17. Phua, J., et al., Characteristics and outcomes of culture-negative versus culture-positive severe sepsis. Critical Care, 2013. 17(5): p. R202.18. Annane, D., E. Bellissant, and J.-M. Cavaillon, Septic shock. The Lancet, 2005. 365(9453): p. 63-78.19. Van Amersfoort, E.S., T.J. Van Berkel, and J. Kuiper, Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock. Clinical microbiology reviews, 2003. 16(3): p. 379-414.20. Martin, G.S., D.M. Mannino, and M. Moss, The effect of age on the development and outcome of adult sepsis*. Critical care medicine,